logo
logo

Orbit Discovery Announces $7.6 Million Funding To Accelerate Growth In Peptide Discovery Business

Jul 20, 2021almost 4 years ago

Amount Raised

$7.6 Million

Oxford

Description

Orbit Discovery Ltd., (“Orbit”), a privately held biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, today announced that it has raised $7.6 million (USD) in funding.

Company Information

Company

Orbit Discovery

Location

Oxford, Mississippi, United States

About

Orbit Discovery provide services to identify therapeutic peptide leads via high throughput affinity and functional screening.